[go: up one dir, main page]

PL1664123T5 - Wytwarzanie w dużej skali inhibitora proteinazy alfa-1 i jego zastosowanie - Google Patents

Wytwarzanie w dużej skali inhibitora proteinazy alfa-1 i jego zastosowanie

Info

Publication number
PL1664123T5
PL1664123T5 PL04770552T PL04770552T PL1664123T5 PL 1664123 T5 PL1664123 T5 PL 1664123T5 PL 04770552 T PL04770552 T PL 04770552T PL 04770552 T PL04770552 T PL 04770552T PL 1664123 T5 PL1664123 T5 PL 1664123T5
Authority
PL
Poland
Prior art keywords
months
alpha
large scale
api
proteinase inhibitor
Prior art date
Application number
PL04770552T
Other languages
English (en)
Other versions
PL1664123T3 (pl
Inventor
Shabtai Bauer
Original Assignee
Kamada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34379546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1664123(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL15805303A external-priority patent/IL158053A0/xx
Application filed by Kamada Ltd filed Critical Kamada Ltd
Publication of PL1664123T3 publication Critical patent/PL1664123T3/pl
Publication of PL1664123T5 publication Critical patent/PL1664123T5/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL04770552T 2003-09-22 2004-09-22 Wytwarzanie w dużej skali inhibitora proteinazy alfa-1 i jego zastosowanie PL1664123T5 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US50390203P 2003-09-22 2003-09-22
IL15805303A IL158053A0 (en) 2003-09-22 2003-09-22 Process for large scale purification of alpha-1 proteinase inhibitor
EP04770552A EP1664123B2 (en) 2003-09-22 2004-09-22 Large scale preparation of alpha-1 proteinase inhibitor and use thereof
PCT/IL2004/000881 WO2005027821A2 (en) 2003-09-22 2004-09-22 Large scale preparation of alpha-1 proteinase inhibitor and use thereof

Publications (2)

Publication Number Publication Date
PL1664123T3 PL1664123T3 (pl) 2008-11-28
PL1664123T5 true PL1664123T5 (pl) 2012-04-30

Family

ID=34379546

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04770552T PL1664123T5 (pl) 2003-09-22 2004-09-22 Wytwarzanie w dużej skali inhibitora proteinazy alfa-1 i jego zastosowanie

Country Status (12)

Country Link
US (2) US7879800B2 (pl)
EP (1) EP1664123B2 (pl)
AT (1) ATE391730T1 (pl)
CA (1) CA2538998C (pl)
DE (1) DE602004013021T3 (pl)
DK (1) DK1664123T4 (pl)
ES (1) ES2305845T5 (pl)
IL (1) IL174410A0 (pl)
PL (1) PL1664123T5 (pl)
PT (1) PT1664123E (pl)
SI (1) SI1664123T2 (pl)
WO (1) WO2005027821A2 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0524432D0 (en) * 2005-11-30 2006-01-11 Nhs Blood & Transplant Method
US7973005B2 (en) 2006-02-09 2011-07-05 Kamada Ltd. Alpha-1 antitrypsin for treating exacerbation episodes of pulmonary diseases
NZ582170A (en) 2007-08-17 2012-02-24 Csl Behring Gmbh Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i
BRPI0915948A2 (pt) * 2008-07-18 2019-04-09 Talecris Biotherapeutics Inc método de preparar inibidor de alfa-1 proteinase
AU2010315325B2 (en) 2009-11-03 2014-11-27 Grifols Therapeutics Inc. Composition, method, and kit for alpha-1 proteinase inhibitor
AU2010324839B2 (en) 2009-11-24 2015-02-19 Grifols Therapeutics Inc. Lyophilization methods, compositions, and kits
US20120329127A1 (en) 2011-05-27 2012-12-27 Baxter Healthcare S.A. Therapeutic proteins with increased half-life and methods of preparing same
MY166314A (en) 2011-12-30 2018-06-25 Grifols Sa Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
US9353165B2 (en) 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
CA3048150A1 (en) * 2016-12-22 2018-06-28 Kamada Ltd. Dry powder formulations of alpha-1 antitrypsin
BR112019017438A2 (pt) * 2017-02-21 2020-05-05 Kamada Ltd uso de alfa-1-antitripsina
ES2984415T3 (es) 2017-12-12 2024-10-29 Kamada Ltd Métodos para inducir tolerancia inmunitaria y reducir la respuesta de anticuerpos anti-fármaco
IL267923B2 (en) 2018-08-02 2023-06-01 Grifols Worldwide Operations Ltd The composition containing the most concentrated alpha-1 type protein inhibitor and a method for obtaining it
WO2020157752A1 (en) * 2019-01-29 2020-08-06 Kamada Ltd Pharmaceutical aerosol composition

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439358A (en) * 1982-06-17 1984-03-27 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
US4697003A (en) * 1985-11-01 1987-09-29 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4656254A (en) * 1985-12-02 1987-04-07 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor and antithrombin III
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
US4749783A (en) * 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
US5093316A (en) * 1986-12-24 1992-03-03 John Lezdey Treatment of inflammation
CA2081774A1 (en) * 1990-05-01 1991-11-02 John Stephen Haskill Interleukin-1 antagonist and uses thereof
US5814225A (en) 1994-06-09 1998-09-29 Shanbrom Technologies Llc Iodinated gel filtration media for disinfecting protein solutions
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
US5610285A (en) * 1994-08-24 1997-03-11 Bayer Corporation Purification of α-1 proteinase inhibitor using novel chromatographic separation conditions
WO1997009350A1 (en) * 1995-09-07 1997-03-13 Ppl Therapeutics (Scotland) Ltd. Purification of alpha-1 proteinase inhibitor
US5780440A (en) * 1996-06-17 1998-07-14 Protease Sciences Inc. Treatment of pulmonary disease with protease inhibitors
TW491855B (en) * 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
AT407114B (de) 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung
US6093804A (en) * 1998-09-24 2000-07-25 American National Red Cross Method for purification of alpha-1 proteinase inhibitor
US6462180B1 (en) * 1999-11-24 2002-10-08 Bayer Corporation Method of preparing α-1 proteinase inhibitor
ES2543829T5 (es) * 2000-12-14 2023-07-13 Grifols Therapeutics Inc Procedimiento para la preparación del inhibidor de proteinasa alfa 1
KR100788093B1 (ko) 2002-04-26 2007-12-21 제넨테크, 인크. 단백질의 비친화성 정제
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
PL1654284T3 (pl) * 2003-08-12 2009-09-30 Octapharma Ag Sposób uzyskiwania roztworu alfa-1-antytrypsyny
CN102924565A (zh) 2004-06-07 2013-02-13 厄普弗朗特色谱公司 血浆或者血清蛋白的分离

Also Published As

Publication number Publication date
US20080139465A1 (en) 2008-06-12
US20110092444A1 (en) 2011-04-21
PT1664123E (pt) 2008-07-16
DK1664123T3 (da) 2008-07-28
ATE391730T1 (de) 2008-04-15
ES2305845T5 (es) 2012-04-12
PL1664123T3 (pl) 2008-11-28
ES2305845T3 (es) 2008-11-01
DK1664123T4 (da) 2012-03-05
SI1664123T1 (sl) 2008-10-31
SI1664123T2 (sl) 2012-03-30
CA2538998C (en) 2015-11-24
EP1664123B2 (en) 2011-11-30
EP1664123A4 (en) 2006-11-02
DE602004013021T2 (de) 2009-06-25
EP1664123A2 (en) 2006-06-07
WO2005027821A3 (en) 2005-08-04
CA2538998A1 (en) 2005-03-31
US7879800B2 (en) 2011-02-01
DE602004013021T3 (de) 2012-04-05
EP1664123B1 (en) 2008-04-09
AU2004273696A1 (en) 2005-03-31
WO2005027821A2 (en) 2005-03-31
DE602004013021D1 (de) 2008-05-21
IL174410A0 (en) 2006-08-01

Similar Documents

Publication Publication Date Title
IL174410A0 (en) Large scale preparation of alpha-1 proteinase inhibitor and use thereof
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
SE0001899D0 (sv) New compounds
BRPI0414176A (pt) inibidores de serina proteases, em particular hcv ns3-ns4a protease
WO2005007681A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
DE60233137D1 (de) Transporter mit beabstandeten arginin-teilchen
HUP0401104A2 (hu) Dipeptidil-peptidáz inhibitorként cukorbetegség megelőzésére és kezelésére alkalmazható (béta-aminoacil)-tetrahidroimidazo[1,2-a]pirazinok és - tetrahidrotriazolo[4,3-a]pirazinok, valamint az ezeket tartalmazó gyógyszerkészítmények
ATE381537T1 (de) Formanilid-derivative als beta2-adrenorezeptor- agonisten
SG166791A1 (en) Novel macrocyclic inhibitors of hepatitis c virus replication
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
GEP20022824B (en) Antipicornaviral Compounds, Pharmaceutical Compositions Containing the Same and Methods for Treatment
ECSP045378A (es) Derivados novedosos de diazabiciclononeno
BR0308765A (pt) Compostos (4,2-dissubstituìdo-tiazol-5-il)amina como inibidores de pde7
SE9904413D0 (sv) Comminuted form
SE9904421D0 (sv) New compounds
MXPA05012675A (es) Compuestos de hidroxiamidina e hidroxiguanidina como inhibidores de urocinasa.
EA200400708A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
WO2005075471A3 (en) Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
ATE494894T1 (de) Viruzide wirkungen von einer zubereitung enthaltend cetylpyridiniumchlorid und zitronensäure
MXPA04001655A (es) Derivados de acido ascorbico, metodos de sintesis y uso farmaceutico de los mismos.
DE602005020314D1 (de) Bicyclononen-derivate als renin-inhibitoren
SE0101978D0 (sv) New compounds
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
EA200400709A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1